• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成人经典特应性皮炎、特应性痒疹和非特应性结节性痒疹患者表皮屏障完整性的比较。

Comparison of Epidermal Barrier Integrity in Adults with Classic Atopic Dermatitis, Atopic Prurigo and Non-Atopic Prurigo Nodularis.

作者信息

Fölster-Holst Regina, Reimer Rahel, Neumann Claudia, Proksch Erhardt, Rodriguez Elke, Weidinger Stephan, Goldust Mohamad, Hanisch Eckhard, Dähnhardt-Pfeiffer Stephan, Freitag-Wolf Sandra

机构信息

Department of Dermatology, Venereology and Allergology, University Hospital Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany.

Department of Dermatology, University Medical Center Mainz, 55101 Mainz, Germany.

出版信息

Biology (Basel). 2021 Oct 7;10(10):1008. doi: 10.3390/biology10101008.

DOI:10.3390/biology10101008
PMID:34681107
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8533604/
Abstract

A deficient epidermal barrier is a key feature of atopic dermatitis (AD) and comprises altered lipid and protein content and composition of the stratum corneum resulting in disturbed water balance. Clinically, eczematous lesions on dry skin and pruritus develop. Pruritic nodules occur in prurigo nodularis (PN), another chronic skin disease, which can be associated with atopy. We aimed at comparing the three clinical pictures, classic AD, atopic prurigo (AP), and non-atopic PN, to healthy controls regarding the epidermal barrier. We determined clinical parameters and performed biophysical measurements, histology/immunohistochemistry, electron microscopy, and molecular biological analysis. We found distinctively elevated clinical scores, reduced hydration and increased transepidermal water loss, epidermal hyperplasia and inflammation reduced filaggrin and increased loricrin and involucrin expression, as well as reduced intercellular lipid lamellae in all three disease groups. These findings show a severe disruption in epidermal barrier structure and function in all three disorders so that epidermal barrier impairment is now proven not only for AD but also for PN.

摘要

表皮屏障功能缺陷是特应性皮炎(AD)的一个关键特征,包括角质层脂质和蛋白质含量及组成的改变,从而导致水平衡紊乱。临床上,干性皮肤会出现湿疹样病变并伴有瘙痒。瘙痒性结节见于结节性痒疹(PN),这是另一种慢性皮肤病,可能与特应性有关。我们旨在比较三种临床情况,即经典AD、特应性瘙痒症(AP)和非特应性PN与健康对照在表皮屏障方面的差异。我们测定了临床参数,并进行了生物物理测量、组织学/免疫组织化学、电子显微镜检查和分子生物学分析。我们发现,在所有三个疾病组中,临床评分显著升高、皮肤水合作用降低、经表皮水分流失增加、表皮增生和炎症、丝聚合蛋白减少、兜甲蛋白和内披蛋白表达增加,以及细胞间脂质层减少。这些发现表明,在所有这三种疾病中,表皮屏障结构和功能均受到严重破坏,因此现在已证实表皮屏障受损不仅存在于AD,也存在于PN。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a867/8533604/2f8df0b6de58/biology-10-01008-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a867/8533604/5a37b805710d/biology-10-01008-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a867/8533604/275984599a3a/biology-10-01008-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a867/8533604/d0e29110bc3c/biology-10-01008-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a867/8533604/2f0b71e468ed/biology-10-01008-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a867/8533604/1a892e28a1a5/biology-10-01008-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a867/8533604/3c75e7bd8c2b/biology-10-01008-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a867/8533604/a04b639403b2/biology-10-01008-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a867/8533604/2f8df0b6de58/biology-10-01008-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a867/8533604/5a37b805710d/biology-10-01008-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a867/8533604/275984599a3a/biology-10-01008-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a867/8533604/d0e29110bc3c/biology-10-01008-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a867/8533604/2f0b71e468ed/biology-10-01008-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a867/8533604/1a892e28a1a5/biology-10-01008-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a867/8533604/3c75e7bd8c2b/biology-10-01008-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a867/8533604/a04b639403b2/biology-10-01008-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a867/8533604/2f8df0b6de58/biology-10-01008-g008.jpg

相似文献

1
Comparison of Epidermal Barrier Integrity in Adults with Classic Atopic Dermatitis, Atopic Prurigo and Non-Atopic Prurigo Nodularis.成人经典特应性皮炎、特应性痒疹和非特应性结节性痒疹患者表皮屏障完整性的比较。
Biology (Basel). 2021 Oct 7;10(10):1008. doi: 10.3390/biology10101008.
2
RNA sequencing reveals the transcriptome profile of the atopic prurigo nodularis with severe itching.RNA 测序揭示了严重瘙痒性特应性痒疹的转录组特征。
Exp Dermatol. 2023 Jan;32(1):30-40. doi: 10.1111/exd.14678. Epub 2022 Oct 9.
3
Nemolizumab: An Innovative Biologic Treatment to Control Interleukin 31, a Key Mediator in Atopic Dermatitis and Prurigo Nodularis.尼莫利珠单抗:一种创新性的生物制剂,用于控制白细胞介素 31,这是特应性皮炎和结节性痒疹的关键介质。
Actas Dermosifiliogr. 2022 Jul-Aug;113(7):674-684. doi: 10.1016/j.ad.2021.12.014. Epub 2021 Dec 23.
4
Atopic dermatitis and the stratum corneum: part 1: the role of filaggrin in the stratum corneum barrier and atopic skin.特应性皮炎与角质层:第1部分:丝聚合蛋白在角质层屏障及特应性皮肤中的作用
J Clin Aesthet Dermatol. 2013 Oct;6(10):16-22.
5
Prurigo nodularis consists of two distinct forms: early-onset atopic and late-onset non-atopic.结节性痒疹有两种不同的类型:早发性特应性和迟发性非特应性。
Dermatology. 1995;190(4):269-76. doi: 10.1159/000246715.
6
Skin Microbiome in Prurigo Nodularis.结节性痒疹的皮肤微生物组。
Int J Mol Sci. 2023 Apr 21;24(8):7675. doi: 10.3390/ijms24087675.
7
Dupilumab in prurigo nodularis: a systematic review of current evidence and analysis of predictive factors to response.结节性痒疹中使用度普利尤单抗:当前证据的系统评价及应答预测因素分析。
J Dermatolog Treat. 2022 May;33(3):1547-1553. doi: 10.1080/09546634.2020.1853024. Epub 2020 Dec 3.
8
Efficacy and safety of vixarelimab, a human monoclonal oncostatin M receptor β antibody, in moderate-to-severe prurigo nodularis: a randomised, double-blind, placebo-controlled, phase 2a study.人源单克隆抑瘤素M受体β抗体维卡瑞单抗治疗中度至重度结节性痒疹的疗效和安全性:一项随机、双盲、安慰剂对照的2a期研究
EClinicalMedicine. 2023 Feb 3;57:101826. doi: 10.1016/j.eclinm.2023.101826. eCollection 2023 Mar.
9
Association between atopic dermatitis and prurigo nodularis: a systematic review and meta-analysis.特应性皮炎与结节性痒疹之间的关联:一项系统评价与荟萃分析。
Int J Dermatol. 2025 Feb;64(2):282-286. doi: 10.1111/ijd.17493. Epub 2024 Sep 29.
10
Single-cell profiling of prurigo nodularis demonstrates immune-stromal crosstalk driving profibrotic responses and reversal with nemolizumab.对结节性痒疹的单细胞分析表明,免疫-基质细胞相互作用驱动成纤维细胞反应,并用 nemolizumab 逆转。
J Allergy Clin Immunol. 2024 Jan;153(1):146-160. doi: 10.1016/j.jaci.2023.07.005. Epub 2023 Jul 26.

引用本文的文献

1
Long-term Progressive Improvement of Atopic Dermatitis by an Herbal Emollient Plus Combination in a 12-week Clinical Trial.一项为期12周的临床试验表明,一种草本润肤剂加联合用药可使特应性皮炎长期逐步改善。
Acta Derm Venereol. 2025 Jun 18;105:adv43026. doi: 10.2340/actadv.v105.43026.
2
A Novel Epidermis Model Using Primary Hidradenitis Suppurativa Keratinocytes.一种使用原发性化脓性汗腺炎角质形成细胞的新型表皮模型。
J Tissue Eng Regen Med. 2024 Feb 27;2024:4363876. doi: 10.1155/2024/4363876. eCollection 2024.
3
Disease burden and treatment satisfaction in patients with prurigo nodularis in Japan.

本文引用的文献

1
Dupilumab in prurigo nodularis: a systematic review of current evidence and analysis of predictive factors to response.结节性痒疹中使用度普利尤单抗:当前证据的系统评价及应答预测因素分析。
J Dermatolog Treat. 2022 May;33(3):1547-1553. doi: 10.1080/09546634.2020.1853024. Epub 2020 Dec 3.
2
Epidemiology of Prurigo Nodularis compared with Psoriasis in Germany: A Claims Database Analysis.德国结节性痒疹与银屑病的流行病学比较:一项索赔数据库分析。
Acta Derm Venereol. 2020 Nov 4;100(18):adv00309. doi: 10.2340/00015555-3655.
3
Atopic dermatitis.特应性皮炎。
日本结节性痒疹患者的疾病负担和治疗满意度。
J Dermatol. 2024 Feb;51(2):223-233. doi: 10.1111/1346-8138.17045. Epub 2023 Dec 8.
4
Thalidomide Responsive Recalcitrant Adult-Onset Atopic Dermatitis - Repurposing an Old Drug.沙利度胺治疗成人顽固性迟发性特应性皮炎——旧药新用
Indian J Dermatol. 2023 Jul-Aug;68(4):470-472. doi: 10.4103/ijd.ijd_728_22.
5
Atopic Dermatitis Across Shades of Skin.特应性皮炎的肤色差异。
Am J Clin Dermatol. 2023 Sep;24(5):731-751. doi: 10.1007/s40257-023-00797-1. Epub 2023 Jun 19.
6
The Acari Hypothesis, III: Atopic Dermatitis.螨类假说,III:特应性皮炎。
Pathogens. 2022 Sep 23;11(10):1083. doi: 10.3390/pathogens11101083.
7
Prurigo Nodularis: A Review of IL-31RA Blockade and Other Potential Treatments.结节性痒疹:IL-31RA阻断及其他潜在治疗方法综述
Dermatol Ther (Heidelb). 2022 Sep;12(9):2039-2048. doi: 10.1007/s13555-022-00782-2. Epub 2022 Aug 20.
8
Dupilumab Significantly Reduces Symptoms of Prurigo Nodularis and Depression: A Case Series.度普利尤单抗显著减轻结节性痒疹症状及抑郁:病例系列报道
Acta Derm Venereol. 2022 Aug 11;102:adv00754. doi: 10.2340/actadv.v102.2151.
Lancet. 2020 Aug 1;396(10247):345-360. doi: 10.1016/S0140-6736(20)31286-1.
4
Assessment of sleep and obesity in adults and children: Observational study.成人与儿童睡眠及肥胖状况评估:观察性研究。
Medicine (Baltimore). 2019 Nov;98(46):e17642. doi: 10.1097/MD.0000000000017642.
5
Effectiveness of Dupilumab for the Treatment of Generalized Prurigo Nodularis Phenotype of Adult Atopic Dermatitis.度普利尤单抗治疗成人特应性皮炎泛发性痒疹样表型的疗效。
Dermatitis. 2020 Jan/Feb;31(1):81-84. doi: 10.1097/DER.0000000000000517.
6
Skin Barrier Damage and Itch: Review of Mechanisms, Topical Management and Future Directions.皮肤屏障损伤与瘙痒:机制、局部治疗及未来方向综述。
Acta Derm Venereol. 2019 Dec 1;99(13):1201-1209. doi: 10.2340/00015555-3296.
7
European S2k Guideline on Chronic Pruritus.欧洲 S2k 慢性瘙痒指南。
Acta Derm Venereol. 2019 Apr 1;99(5):469-506. doi: 10.2340/00015555-3164.
8
Influence of Topical Formulations: Lipid Lamella Organization and Lipid Composition of Stratum Corneum as a Surrogate Marker for Barrier Integrity.局部制剂的影响:角质层的脂质片层结构和脂质组成作为屏障完整性的替代标志物
Curr Probl Dermatol. 2018;54:166-172. doi: 10.1159/000489530. Epub 2018 Aug 21.
9
Prurigo Activity Score (PAS): validity and reliability of a new instrument to monitor chronic prurigo.瘙痒活动评分 (PAS):一种监测慢性瘙痒的新工具的有效性和可靠性。
J Eur Acad Dermatol Venereol. 2018 Oct;32(10):1754-1760. doi: 10.1111/jdv.15040. Epub 2018 Jun 7.
10
Stress-related eating, mindfulness, and obesity.与压力相关的进食行为、正念和肥胖。
Health Psychol. 2018 Jun;37(6):516-525. doi: 10.1037/hea0000614. Epub 2018 Apr 30.